Home › Funds › WAYCROSS PARTNERS, LLC › ABBV

WAYCROSS PARTNERS, LLC position in ABBV

ABBVIE INC · Health Care

WAYCROSS PARTNERS, LLC reported holding 168,170 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$44.0M, representing 3.42% of its reported portfolio and ranking #8 among its reported holdings. WAYCROSS PARTNERS, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)168.17K sh
Reported value held$43.99M
Portfolio Weight3.42%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WAYCROSS PARTNERS, LLC's ABBV position evolved

WAYCROSS PARTNERS, LLC first disclosed a stake in ABBV in Q3 2023 at 114,749 shares (US$17.1M). The position peaked in Q3 2026 at 168,170 shares, worth US$44.0M. Across 13 filings, WAYCROSS PARTNERS, LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 168,170 shares valued at US$44.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 114.75K $17.10M New
Q4 2023 109.65K $16.99M Reduce
Q1 2024 116.18K $21.16M Add
Q2 2024 128.27K $22.00M Add
Q3 2024 130.99K $25.87M Add
Q4 2024 135.00K $23.99M Add
Q1 2025 157.29K $32.95M Add
Q2 2025 169.34K $31.43M Add
Q3 2025 177.41K $41.08M Add
Q4 2025 182.48K $41.69M Add
Q1 2026 165.94K $36.09M Reduce
Q2 2026 167.93K $42.26M Add
Q3 2026 168.17K $43.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has WAYCROSS PARTNERS, LLC held ABBV?

WAYCROSS PARTNERS, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WAYCROSS PARTNERS, LLC's current position in ABBV?

As of Q3 2026, WAYCROSS PARTNERS, LLC holds 168.17K shares of ABBV (ABBVIE INC), valued at $43.99M, representing 3.42% of its reported portfolio and ranking #8.

Has WAYCROSS PARTNERS, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), WAYCROSS PARTNERS, LLC held unchanged its position in ABBV. The position peaked in Q3 2026 at 168.17K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.